CSIMarket



Sangui Biotech International Inc  (SGBI)
Other Ticker:  
 
 

SGBI's Capital Expenditures Growth by Quarter and Year

Sangui Biotech International Inc's Capital Expenditures results by quarter and year




SGBI Capital Expenditures (in millions $) FY 2022 FY 2021 FY 2020 FY 2019
IV Quarter June - - - -
III Quarter March 0.00 - - -
II Quarter December - - - -
I Quarter September - - - -
FY   - - - -



SGBI Capital Expenditures third quarter 2022 Y/Y Growth Comment
Sangui Biotech International Inc in the third quarter 2022 recorded Capital Expenditures of $ 0.00 millions.

According to the results reported in the third quarter 2022, Sangui Biotech International Inc achieved the best Capital Expenditures growth in Biotechnology & Pharmaceuticals industry. While Sangui Biotech International Inc' s Capital Expenditures no change of % ranks overall at the positon no. in the third quarter 2022.




SGBI Capital Expenditures ( Y/Y Growth %) 2022
2021 2020 2019
IV Quarter June - - - -
III Quarter March - - - -
II Quarter December - - - -
I Quarter September - - - -
FY   - - - -

Financial Statements
Sangui Biotech International Inc's third quarter 2022 Capital Expenditures $ 0.00 millions SGBI's Income Statement
Sangui Biotech International Inc's third quarter 2021 Capital Expenditures $ 0.00 millions Quarterly SGBI's Income Statement
New: More SGBI's historic Capital Expenditures Growth >>


SGBI Capital Expenditures (Quarter on Quarter Growth %)

2022
2021 2020 2019
IV Quarter June - - - -
III Quarter March - - - -
II Quarter December - - - -
I Quarter September - - - -
FY (Year on Year)   - - - -




Capital Expenditures third quarter 2022 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #

Capital Expenditures Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
Capital Expenditures third quarter 2022 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #
Capital Expenditures Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

Capital Expenditures by Quarter for the Fiscal Years 2019, 2020, 2021, 2022

Sangui Biotech International Inc's Q/Q Capital Expenditures Growth


Capital Expenditures Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


SGBI's III. Quarter Q/Q Capital Expenditures Comment


Capital Expenditures Q/Q Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #
Capital Expenditures Q/Q Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #
Capital Expenditures Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


SGBI's III. Quarter Q/Q Capital Expenditures Comment


Sangui Biotech International Inc's 12 Months Capital Expenditures Growth Year on Year


Capital Expenditures TTM Growth

12 Months Ending
(Mar 31 2022)
12 Months Ending
(Dec 31 2021)
12 Months Ending
(Sep 30 2021)
12 Months Ending
(Jun 30 2021)
12 Months Ending
(Mar 31 2021)
Cumulative Capital Expenditures 12 Months Ending $ 0.00 $ 0.00 $ 0.00 $ 0.00 $ 0.00
Y / Y Capital Expenditures Growth (TTM) - - - - -
Year on Year Capital Expenditures Growth Overall Ranking # # # # #
Seqeuential Capital Expenditures Change (TTM) - - - - -
Seq. Capital Expenditures Growth (TTM) Overall Ranking # # # # #




Cumulative Capital Expenditures growth Comment
In the Mar 31 2022 period, Sangui Biotech International Inc's cumulative trailing twelve month Capital Expenditures remained unchanged compare to the same period a year ago.

Sangui Biotech International Inc achieved highest trailing twelve month year on year Capital Expenditures growth. While overall Capital Expenditures growth ranking, remained unchanged compare to the previous quarter at no. .

Capital Expenditures TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

Capital Expenditures TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #

Capital Expenditures TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Capital Expenditures TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative Capital Expenditures growth Comment
In the Mar 31 2022 period, Sangui Biotech International Inc's cumulative trailing twelve month Capital Expenditures remained unchanged compare to the same period a year ago.

Sangui Biotech International Inc achieved highest trailing twelve month year on year Capital Expenditures growth. While overall Capital Expenditures growth ranking, remained unchanged compare to the previous quarter at no. .

Capital Expenditures TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


Capital Expenditures TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #

Capital Expenditures TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Capital Expenditures TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other Capital Expenditures Growth
Biotechnology & Pharmaceuticals Industry Capital Expenditures Growth Trends and Statistics
Healthcare Sector Capital Expenditures Growth Statistics
Capital Expenditures Growth Trends for overall market
SGBI's Capital Expenditures Growth Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Capital Expenditures Growth
Lowest Ranking Capital Expenditures Growth
Capital Expenditures Growth for SGBI's Competitors
Capital Expenditures Growth for Sangui Biotech International Inc's Suppliers
Capital Expenditures Growth for SGBI's Customers

You may also want to know
SGBI's Annual Growth Rates SGBI's Profitability Ratios SGBI's Asset Turnover Ratio SGBI's Dividend Growth
SGBI's Roe SGBI's Valuation Ratios SGBI's Financial Strength Ratios SGBI's Dividend Payout Ratio
SGBI's Roa SGBI's Inventory Turnover Ratio SGBI's Growth Rates SGBI's Dividend Comparisons



Companies with similar Capital Expenditures no change for the quarter ending Mar 31 2022 within Healthcare SectorY/Y Change %Capital Expenditures for the quarter ending Mar 31 2022
Novan Inc.-0.64%$ -0.642 millions
Brookdale Senior Living Inc.-1.00%$ -1.003 millions
Steris Plc-2.26%$ -2.264 millions
Alkermes Plc.-2.44%$ -2.442 millions
Novabay Pharmaceuticals Inc.-4.00%$ -4.000 millions
Shattuck Labs Inc.-5.69%$ -5.686 millions
Morphic Holding inc.-5.88%$ -5.882 millions
Fulcrum Therapeutics Inc.-6.11%$ -6.107 millions
Vbi Vaccines Inc-7.37%$ -7.374 millions
Community Health Systems Inc.-7.62%$ -7.619 millions
Sqz Biotechnologies Company-7.69%$ -7.692 millions
Tarsus Pharmaceuticals Inc.-8.00%$ -8.000 millions
Inspire Medical Systems inc.-8.02%$ -8.024 millions
Becton Dickinson And Company-10.28%$ -10.277 millions
Vertex Pharmaceuticals Inc-10.33%$ -10.329 millions
Xtant Medical Holdings Inc.-10.70%$ -10.701 millions
Myriad Genetics Inc.-11.27%$ -11.268 millions
Exact Sciences Corporation-11.33%$ -11.332 millions
Inogen Inc.-11.41%$ -11.414 millions
Alphatec Holdings Inc.-11.81%$ -11.808 millions
Avanos Medical Inc.-12.28%$ -12.281 millions
Merck and Co. Inc.-13.23%$ -13.228 millions
Genocea Biosciences Inc -13.35%$ -13.345 millions
Abbvie Inc.-13.83%$ -13.830 millions
Acadia Healthcare Company Inc.-13.90%$ -13.897 millions
Procyon Corp-14.32%$ -14.319 millions
Ocugen Inc.-14.56%$ -14.559 millions
Therapeutic Solutions International Inc.-14.97%$ -14.974 millions
Davita Inc.-15.05%$ -15.047 millions
Biolife Solutions Inc-15.35%$ -15.349 millions


       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

PTRA's Profile

Stock Price

PTRA's Financials

Business Description

Fundamentals

Charts & Quotes

PTRA's News

Suppliers

PTRA's Competitors

Customers & Markets

Economic Indicators

PTRA's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2022 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071